Terms: = Thyroid cancer AND SSX2, HD21, 6757, ENSG00000157950, SSX, HOM-MEL-40, MGC3884, MGC15364, MGC119055, RP11-552J9_2 AND Prognosis
2523 results:
1. Rare Columnar Cell Variant of Papillary thyroid Carcinoma with Cervical Spine Metastasis: A Case Report.
Yu J; Yang G; Oh HY; Ryu YJ
Curr Med Imaging; 2024; 20(1):e15734056300884. PubMed ID: 38752631
[TBL] [Abstract] [Full Text] [Related]
2. RPGRIP1L as a new biomarker for prognosis and tumor immune of breast cancer.
Yi J; Liu L; Chen Y; Ding T; Fan P; Yu J; Zeng J
FASEB J; 2024 May; 38(9):e23624. PubMed ID: 38747001
[TBL] [Abstract] [Full Text] [Related]
3. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
[TBL] [Abstract] [Full Text] [Related]
4. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
5. A Competing Risk Nomogram for Prediction of prognosis in Patients With Primary Squamous Cell thyroid Carcinoma.
Tian Y; He L; Zhang B; Deng L; Wang J
Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
[No Abstract] [Full Text] [Related]
6. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
7. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract] [Full Text] [Related]
8. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC?
Ma W; Guo Y; Hua T; Li L; Lv T; Wang J
Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400
[TBL] [Abstract] [Full Text] [Related]
9. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
Yu X; He Z; Wang Z; Ke S; Wang H; Wang Q; Li S
Exp Cell Res; 2024 May; 438(2):114053. PubMed ID: 38663476
[TBL] [Abstract] [Full Text] [Related]
10. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
Shen J; Ma Z; Yang J; Qu T; Xia Y; Xu Y; Zhou M; Liu W
BMC Cancer; 2024 Apr; 24(1):511. PubMed ID: 38654205
[TBL] [Abstract] [Full Text] [Related]
11. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
Lv J; Zhang J; Wu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
[TBL] [Abstract] [Full Text] [Related]
12. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Fang Q; Yuan J; Zhang X; Dai L; Luo R; Xu C
Oral Oncol; 2024 May; 152():106810. PubMed ID: 38631065
[TBL] [Abstract] [Full Text] [Related]
13. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study.
Huang J; Wang J; Xv J; Wang J; Wang G; Zhao Y
Clin Exp Med; 2024 Apr; 24(1):76. PubMed ID: 38607456
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
[TBL] [Abstract] [Full Text] [Related]
15. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
16. BRAF
Zhao H; Liu CH; Lu Y; Liu SZ; Yeerkenbieke P; Cao Y; Xia Y; Gao LY; Liu YW; Liu ZW; Chen SG; Liang ZY; Li XY
Oral Oncol; 2024 May; 152():106755. PubMed ID: 38547780
[TBL] [Abstract] [Full Text] [Related]
17. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated thyroid Carcinomas.
Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448
[TBL] [Abstract] [Full Text] [Related]
18. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
19. DNA Methylation-Regulated HOXC8's Role in HER2-Positive Breast cancer Function and its Contribution to Herceptin Resistance.
Xie X; Tang S; Yu Z
Discov Med; 2024 Mar; 36(182):559-570. PubMed ID: 38531796
[TBL] [Abstract] [Full Text] [Related]
20. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
[Next]
